Investorideas.com breaking new for AI, drones, GPS and technology

Thursday, January 21, 2021

#AIEye #Podcast 511: GBT Technologies (OTCPINK: $GTCH) Begins Research on AI-Powered #Robots for Medical Application, Unisys (NYSE: $UIS) to Research AI and ML to Detect “Deceitful and Persuasive Writing”

#AIEye #Podcast 511: GBT Technologies (OTCPINK: $GTCH) Begins Research on AI-Powered #Robots for Medical Application, Unisys (NYSE: $UIS) to Research AI and ML to Detect “Deceitful and Persuasive Writing”

 

Global Smart Robot Market to Reach $31.11 Billion by 2027

 


Point Roberts WA, Vancouver BC – January 21, 2021  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence    featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2021/012121-AI-Eye.mp3

 

Read this in full at https://www.investorideas.com/news/2021/artificial-intelligence/01211GTCH-UIS.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

Stocks discussed: (OTCPINK:GTCH) (NYSE:UIS)

 

GBT Technologies Inc. (OTC PINK:GTCH) has announced that it is beginning new research targeting medical application robotics, empowered by its AI system. GBT’s CTO, Danny Rittman, explained:

 

"The field of robotics is under constant development in many areas of our daily lives. One of the popular fields that robotics researchers invest major efforts, is the medical arena. Today's robots can take patient's vitals, assist with prosthetics, perform an endoscopy (looking inside the human body typically via Camera) and complex surgeries. As the demand for less invasive, less painful, high precision procedures is rapidly growing, we will be evaluating our AI system for these types of procedures. Our goal is to utilize a high precision mechanical arm based robotic system in simulated medical procedures supervised by an expert system. The plan is to investigate into soft tissues ultra-fine laser incisions, 3D imaging, and intelligent navigation to organs sites of interest. Our goal is to develop low and high level programs to command robotic mechanisms for various physicians assisting tasks. Our research will involve full robotic automation, a physician assistant, and a combination of both. The research is planned to be on-going and we plan to produce technical papers with conclusions and results. Based on our results, we will then seek commercial partners in this domain."

 

Unisys Corporation (NYSE:UIS) announced that the Artificial Intelligence (AI) for Decision Making Initiative – a collaboration between Australia’s Office of National Intelligence (ONI) and Department of Defence –  has awarded Unisys research funding to investigate using AI and Machine Learning (ML) to detect deceitful and persuasive writing. Xin Xu, practice lead for Artificial Intelligence, Machine Learning & Data Science for Unisys Asia Pacific, explained:

 

"Ultimately we want to be able to detect if an author's writing style has changed in documents making exaggerated claims. Real world applications could potentially include forensic analysis to determine who is the true author of a written piece for legal purposes; identify if emails or text messages are written by imposters such as hackers or phishers; or even detect fraudulent of fake statements on Twitter or other public information platforms designed to confuse media or the public.”

 

 

Global Smart Robot Market to Reach $31.11 Billion by 2027

 

A report published by Fortune Business Insights finds that the global Smart Robot market will grow from $5.98 billion in 2019 to $31.11 billion by 2027 with a compound annual growth rate (CAGR) of 23.1 percent in the forecast period 2020-2027. An excerpt from the report summary reads:

 

The emergence of artificial intelligence (AI) into the field of robotics has transformed the whole landscape by providing robots with enough human-like intelligence. AI-powered robots can learn, acclimatize, and respond to more and more complex environments or situations. AI simulators are progressively becoming accurate to drive real-world applications in an efficient way. These simulators can run hundreds of iterative processes within seconds, generating massive amounts of valuable data. This data can be useful for making the robot more intelligent and decisive. So, the demand for AI technology in intelligent robots is growing each day.

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

About GBT Technologies Inc.

GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development-stage company which considers itself a native IoT creator, developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology platforms.  GBT has a portfolio of Intellectual Property that, when commercialized, will include smart microchips, mobile and security applications and protocols, and supporting cloud software.  GBT’s system envisions the creation of a global mesh network.  The core of the system will be its advanced microchip technology that can be installed in any mobile or fixed device worldwide. GBT envisions this system as a low-cost, secure, private mesh network between any enabled devices, providing shared processing, advanced mobile database management/sharing and enhanced mobile features as an alternative to traditional carrier services.

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

 

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com 

Disclosure: GTCH is a paid featured AI stock on Investorideas.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 




Get more Technology stock investor ideas - news, articles, podcasts and stock directories

#AI #Health #Stock News: GBT (OTCPINK: $GTCH) Researching AI based, #Robotics #Technology for the Medical Field

 



 

#AI #Health #Stock News: GBT (OTCPINK: $GTCH) Researching AI based, #Robotics #Technology for the Medical Field

 

San Diego, CA, January 21, 2021 – (Investorideas.com Newswire) GBT Technologies Inc. (OTCPINK: GTCH) ("GBT”, or the “Company”) is researching AI based, robotics technology for the medial field. Due to the expected growth in the global medical robotics industry through 2023*, a wide range of robots are being developed to serve in a variety of roles within the medical environment.  Probably one of the most famous medicals robot is the da Vinci Surgical System**, that was approved by the FDA in 2000. This system is designed to perform minimally invasive surgeries and is controlled by a surgeon from a console.

 

Read this news, featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2021/01211Robotics-Technology-Medical-Field.asp

 

GBT is commencing new research that is targeting medical application robotics, empowered by its AI system. In this research, the Company will focus on the innovation and technological advancements that is offered by AI to enable medical robots achieving higher standards. Using AI technology, robots can perform minimally invasive procedures with high accuracy and precision. For example, performing laser incisions on soft tissue, especially for microsurgeries. Using expert system guidance, one of the research goals, is to perform robotic based laser incisions simulation based on surgeon high level commands where an AI engine controls a high precision laser beam to achieve a desired incision shape, length, and depth. Another planned topic to be researched is robotic assistance for biopsies where under robotic guidance a surgeon can performs a biopsy based on 3D imaging of the area. The Company plans to develop simulated procedures and flows to be tested for further medical purposes.

 

“The field of robotics is under constant development in many areas of our daily lives. One of the popular fields that robotics researchers invest major efforts, is the medical arena. Today’s robots can take patient’s vitals, assist with prosthetics, perform an endoscopy (looking inside the human body typically via Camera) and complex surgeries. As the demand for less invasive, less painful, high precision procedures is rapidly growing, we will be evaluating our AI system for these types of procedure. Our goal is to utilize a high precision mechanical arm based robotic system in simulated medical procedures supervised by an expert system. The plan is to investigate into soft tissues ultra-fine laser incisions, 3D imaging, and intelligent navigation to organs sites of interest. Our goal is to develop low and high level programs to command robotic mechanism for various physicians assisting tasks. Our research will involve full robotic automation, a physician assistant, and a combination of both. The research is planned to be on-going and we plan to produce technical papers with conclusions and results. Based on our results, we will then seek commercial partners in this domain,” said Danny Rittman the Company’s CTO.

 

 *Source: Medical Robotics Market To Reach Over US$ 20 Bn By 2023 - Credence Research

**   Source:  da Vinci Surgical System - Wikipedia

 

About Us

GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.


Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements".  Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov).  In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products.  The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change.  However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.  These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

 

Contact:

Dr. Danny Rittman, CTO
press@gopherprotocol.com

 

GBT Technologies Inc. (OTCQB:GTCH) is a featured tech stock on

Investorideas.com

 

More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

 

Get News Alerts on GBT Technologies Inc GTCH

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp

Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 


  Get more tech stocks investor ideas- news, articles, podcasts and stock directories

 

 

 

 

 

 

 

Tuesday, January 19, 2021

#AIEye #Podcast 510: #Stocks discussed: (NYSE: $IBM) (OTC: $AEXAY) (NYSE: $INFY) (NasdaqGS: $NVDA)



 

 

#AIEye #Podcast 510: #Stocks discussed: (NYSE: $IBM) (OTC: $AEXAY) (NYSE: $INFY) (NasdaqGS: $NVDA)

 

IBM (NYSE: $IBM) and Atos (OTC: $AEXAY) Expanding Alliance to Help Companies Accelerate Digital Transformation with #AI and #Cloud, Infosys (NYSE: $INFY) Launching NVIDIA-Powered (NasdaqGS: $NVDA) AI Cloud

 

Global AI in Healthcare to Reach $61.59 Billion by 2027

 

Point Roberts WA, Vancouver BC – January 19, 2021  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2021/011921-AI-Eye.mp3

 

Read this in full at https://www.investorideas.com/news/2021/artificial-intelligence/01191IBM-INFY-NVDA.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

Stocks discussed: (NYSE:IBM) (OTC:AEXAY) (NYSE:INFY) (NasdaqGS:NVDA)

 

IBM (NYSE:IBM) and information tech services firm Atos (OTC:AEXAY) have announced the expansion of their strategic global alliance to help companies accelerate their digital transformation and optimize business processes. According to the press release, this will give clients access “to industry-specific automation solutions using AI and hybrid cloud technologies to enable digital acceleration and increase productivity and reduce costs.” Bob Lord, SVP Cognitive Applications and Ecosystems, IBM, said:

 

“Expanding IBM's alliance with Atos reinforces our mission to work with some of the most forward-thinking, customer-centric ecosystem partners in the world to accelerate client digital transformations. Atos delivers leading solutions that optimize business processes to produce tangible outcomes for asset-heavy industries. Combining Atos' industry-specific knowledge and commitment to sustainability with IBM's deep experience in AI and open hybrid cloud technology is critical to help clients modernize."

 

Digital services firm Infosys Limited (NYSE:INFY) announced the launch of a new applied AI cloud, through Infosys Cobalt, and powered by NVIDIA DGX A100 systems (NasdaqGS:NVDA), that will provide Infosys employees with “simple and fast access to AI infrastructure.” Balakrishna D.R., Senior VP, Head - AI & Automation Services, Infosys, explained:

 

"For a long time now, AI has been playing a key role in shaping consumer experience. Cloud, data analytics and AI are now converging to bring the opportunity for enterprises to not just drive consumer experience but reimagine processes and capabilities too. Infosys applied AI cloud, powered by NVIDIA DGX A100 systems, can help enterprises to quickly build on the opportunity, while scaling with new technological advancements."

 

 

Global AI in Healthcare to Reach $61.59 Billion by 2027

 

Research published by Reports and Data finds that the global AI in Healthcare market will reach $61.59 billion in 2027, registering a compound annual growth rate (CAGR) of 43.6 percent in the forecast period 2017-2027. An excerpt from the report description reads:

 

Artificial intelligence (AI) in healthcare market revenue growth is driven by increasing efficiency in drug discovery and advancements in precision medicine, which is resulting in rising demand and application of these solutions globally. Rising prevalence of chronic diseases and increasing global elderly population is expected to continue to support growth of the market.

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

 

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 




Get more Technology stock investor ideas - news, articles, podcasts and stock directories